Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK appoints new head of public affairs and campaigning

Layla Theiner will drive the charity’s public affairs and campaigning activities across the UK and EU

Cancer Research UK has promoted Layla Theiner from EU public affairs manager to head of public affairs and campaigning.

Reporting to head of policy Sara Osborne, Theiner's new role will involve driving the charity's public affairs and campaigning activities across the UK and EU. 

During her time as EU public affairs manager, which commenced in 2010, Theiner developed the charity's EU public affairs strategy and was responsible for communicating its position on EU legislation, while also influencing and improving relevant policy.

She has experience working with politicians, advisers and civil servants around issues such as clinical trial regulation, support for cancer research and packaging of tobacco products.

Theiner also set up the EU-UK Health and Science Policy Group, which comprises of 15 representatives from medical research charities and other organisations in the UK.

Prior to joining the charity, Theiner worked as a senior associate for APCO Worldwide, a consultant at Lexington Communications and an account executive at Citigate Public Affairs.

14th November 2012

From: Marketing, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics